En Es
Categories

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, electrochemistry, immunoassay, hematology and spectrophotometry products among others. The company’s biomedical laboratory instruments and diagnostic solutions, as well as automated and integrated data managemen ...
Products Covid-19NewsSummary
Close

Covid-19 BECKMAN COULTER, INC.

Clinical Laboratory

SARS-CoV-2 IgG Antibody Test
Access SARS-CoV-2 IgG Antibody Test

The Access SARS-CoV-2 IgG Antibody Test is designed to target antibodies against the coronavirus spike protein that may be more likely to confer immunity and detects antibodies to the RBD (Receptor Binding Domain) of the spike protein. The assay features market-leading 100% sensitivity‡ and 99.8% specificity, and is being validated against over 1,000 negative broad population-based samples.
More details

SARS-CoV-2 (COVID-19) Antibody Test
Access SARS-CoV-2 IgM Antibody Test

The Access SARS-CoV-2 IgM Antibody Test targets antibodies that recognize the receptor binding domain (RBD) of the spike protein which SARS-CoV-2 uses to bind to a human cell receptor. The IgM antibody test demonstrated 99.9% specificity against 1,400 negative samples and 98.3% sensitivity at 15-30 days post-symptom onset, and provides information about an individual's immune status with a positive predicative value of 95.5% in a population with disease incidence as low as 3%.
More details

SARS-CoV-2 IgG Antibody Test
Access SARS-CoV-2 IgG Antibody Test

The Access SARS-CoV-2 IgG antibody test detects antibodies to the RBD (Receptor Binding Domain) of the spike protein and can be run in random access mode, seamlessly integrating into current laboratory workflow without the need for batching or special maintenance. The test features market-leading sensitivity and specificity along with its throughput on Beckman Coulter immunoassay and integrated systems leading the industry at up to 200 tests per hour depending on the analyzer used (up to 4,800 tests/day).
More details

SARS-CoV-2 Antibody Test
Access SARS-CoV-2 IgG II Assay

The Access SARS-CoV-2 IgG II assay is a semi-quantitative and qualitative immunoassay that measures IgG antibodies directed to the receptor-binding domain of the spike protein of the novel coronavirus in response to a previous infection. The assay then provides a numerical result ranging from 2.00-450/mL1 as well as a qualitative result for SARS-CoV-2 IgG antibodies and can be used in Random Access Mode (RAM) as well as seamlessly integrated into existing workflows without batch processing.
More details
Close

News of BECKMAN COULTER, INC.

Beckman Coulter Launches New DxH 560 AL Tabletop Hematology Analyzer for Small- and Medium-Sized Labs

01 Feb 2021
Beckman Coulter Launches New DxH 560 AL Tabletop Hematology Analyzer for Small- and Medium-Sized Labs
Beckman Coulter (Brea, CA, USA) has launched the new DxH 560 AL, a tabletop hematology analyzer geared to reduce the time and resource constraints faced by small to mid-sized laboratories.
Read More

Beckman Coulter presenta una nueva solución de automatización total de laboratorios

29 May 2019
Beckman Coulter presenta una nueva solución de automatización total de laboratorios
La última incorporación de Beckman Coulter (Brea, CA, EUA) a su cartera de automatización, la solución de automatización total de laboratorios, DxA 5000, ha logrado la aprobación de la Marca CE Europea y de la Administración de Alimentos y Medicamentos de China. El primero de un conjunto de sistemas DxA, actualmente en desarrollo, el DxA 5000 mejora la cartera completa de soluciones escalables de Beckman Coulter y es un componente clave de su visión para llevar la automatización del flujo de trabajo a los laboratorios de todos los tamaños. 
Read More

Beckman Coulter Introduces New Total Laboratory Automation Solution

20 May 2019
Beckman Coulter Introduces New Total Laboratory Automation Solution
Beckman Coulter’s latest addition to its automation portfolio, the DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval.
Read More

Beckman Coulter Life Sciences hace una sociedad con Apostle

05 Mar 2019
Beckman Coulter Life Sciences hace una sociedad con Apostle
Beckman Coulter Life Sciences (Indianápolis, IN, EUA) se asoció con Apostle Inc. (Menlo Park, CA, EUA) para el lanzamiento del kit de aislamiento de ADN libre de células de alta eficiencia, MiniMax de Apostle, un kit magnético basado en nanopartículas para extraer ADN libre circulante (cfADN) del plasma mediante flujos de trabajo manuales o automáticos. 
Read More

Beckman Coulter Life Sciences Enters Partnership with Apostle

01 Mar 2019
Beckman Coulter Life Sciences Enters Partnership with Apostle
Beckman Coulter Life Sciences has entered into a partnership with Apostle Inc. for the launch of Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit, a magnetic nanoparticle-based kit to extract circulating free DNA (cfDNA) from plasma using manual or automated workflows.
Read More

Beckman Coulter lanza el Sistema ClearLLab 10C para los laboratorios de citometría de flujo

30 Jan 2019
Beckman Coulter lanza el Sistema ClearLLab 10C para los laboratorios de citometría de flujo
 Beckman Coulter (Brea, CA, EUA) ha lanzado el Sistema ClearLLab 10C para los laboratorios de citometría de flujo que incluye los primeros 10 paneles CE-IVD a color de reactivos de inmunotipificación tanto para el linaje linfoide como mieloide. Los cuatro paneles ClearLLab 10C fueron diseñados específicamente para ser procesados en los citómetros de flujo, Navios y Navios EX de Beckman Coulter, con el nuevo software avanzado de configuración de compensación, Navios.
Read More

Beckman Coulter Launches ClearLLab 10C System for Clinical Flow Cytometry Labs

23 Jan 2019
Beckman Coulter Launches ClearLLab 10C System for Clinical Flow Cytometry Labs
Beckman Coulter has launched the ClearLLab 10C System for clinical flow cytometry labs that includes the first 10-color CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages.
Read More
Close

About BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, electrochemistry, immunoassay, hematology and spectrophotometry products among others. The company’s biomedical laboratory instruments and diagnostic solutions, as well as automated and integrated data management systems, are suitable for diagnosing diseases, making treatment decisions and monitoring patients in hospitals and other critical care settings.
FaceBook Twitter Google+ Linked in
Hematology Analyzer

Hematology Analyzer

Model: DxH 560 AL
Request Information

Description:

The DxH 560 AL is a tabletop hematology analyzer is geared to reduce the time and resource constraints faced by small to mid-sized laboratories. With the analyzer's Auto-Loading functionality, closed tube aspiration and walkaway capabilities, users can continually add up to 50 samples, provide safety against blood-borne pathogens and spend less time on manual instrument tasks.
Read More

Full Description Features

Description

The DxH 560 AL is a tabletop hematology analyzer is geared to reduce the time and resource constraints faced by small to mid-sized laboratories. With the analyzer's Auto-Loading functionality, closed tube aspiration and walkaway capabilities, users can continually add up to 50 samples, provide safety against blood-borne pathogens and spend less time on manual instrument tasks. The DxH 560 AL delivers results in 60 seconds or less, and is the ideal instrument to use with difficult-to-draw patients (infants, oncology and elderly) as it only needs a 17 μL sample – less than a drop of blood, one of the smallest aspiration volumes on the market. Request Information

Features

• Save time and resources: with a multi-tube, compact hematology analyzer that has proven reliability, paperless data management and autonomous instrument daily cleaning

• Available when you need it: the DxH 560 AL is engineered for high uptime and system reliability at less than one service call per year

• Eliminate system readiness delays: experience hands-free, autonomous daily cleaning and startup. The DxH 560 AL was designed with reliability in mind and allows for high walkaway time with autonomous daily start-up and system checks, hands-free daily cleaning, plus simple and few reagent replacements for maximized uptime

• Load and go up to 50 samples: with on-the-fly continuous loading more than twice the capacity compared to the closest competitor

• Only needs a 17 μL sample, one of the smallest sample volumes on the market

• Results in 60 seconds or less

• Extended QC (eQC): with onboard bias, precision and accuracy monitoring without the need for internet or extra fees

• Reduce administrative errors and go paperless: designed to work as hard as you do, the onboard data management in the DxH 560 AL can host up to 30,000 patient records—equivalent to a year’s worth of tests with typical usage

• Keep analysis running smoothly throughout the day: store and manage just three reagents, with simple and quick replacement, compared to six reagents with other analyzers in its class

• Test in tight spaces: with an integrated monitor and keyboard and only one external reagent, the DxH 560AL requires up to 1/3 less laboratory counter space than other analyzers in its class Request Information

Send A Message To This Supplier

* Required Information
* Email
To
BECKMAN COULTER, INC. (Hematology Analyzer)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions